These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14565616)

  • 1. Adherence to HAART and its principal determinants in a cohort of Senegalese adults.
    Lanièce I; Ciss M; Desclaux A; Diop K; Mbodj F; Ndiaye B; Sylla O; Delaporte E; Ndoye I
    AIDS; 2003 Jul; 17 Suppl 3():S103-8. PubMed ID: 14565616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to antiretroviral drugs and AIDS management in Senegal.
    Desclaux A; Ciss M; Taverne B; Sow PS; Egrot M; Faye MA; Lanièce I; Sylla O; Delaporte E; Ndoye I
    AIDS; 2003 Jul; 17 Suppl 3():S95-101. PubMed ID: 14565615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
    Etard JF; Lanièce I; Fall MB; Cilote V; Blazejewski L; Diop K; Desclaux A; Ecochard R; Ndoye I; Delaporte E;
    Trop Med Int Health; 2007 Oct; 12(10):1191-8. PubMed ID: 17956501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis.
    Bastard M; Fall MB; Lanièce I; Taverne B; Desclaux A; Ecochard R; Sow PS; Delaporte E; Etard JF
    J Acquir Immune Defic Syndr; 2011 May; 57(1):55-61. PubMed ID: 21775934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of adherence to antiretroviral treatment among HIV patients on first-line regimen: a cross-sectional study in Dakar, Senegal.
    Mbengue MAS; Sarr SO; Diop A; Ndour CT; Ndiaye B; Mboup S
    Pan Afr Med J; 2019; 33():95. PubMed ID: 31489073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.
    Laurent C; Diakhaté N; Gueye NF; Touré MA; Sow PS; Faye MA; Gueye M; Lanièce I; Touré Kane C; Liégeois F; Vergne L; Mboup S; Badiane S; Ndoye I; Delaporte E
    AIDS; 2002 Jul; 16(10):1363-70. PubMed ID: 12131213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
    Vergne L; Kane CT; Laurent C; Diakhaté N; Gueye NF; Gueye PM; Sow PS; Faye MA; Liégeois F; Ndir A; Lanièce I; Peeters M; Ndoye I; Mboup S; Delaporte E
    AIDS; 2003 Jul; 17 Suppl 3():S31-8. PubMed ID: 14565607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire.
    Eholié SP; Tanon A; Polneau S; Ouiminga M; Djadji A; Kangah-Koffi C; Diakité N; Anglaret X; Kakou A; Bissagnené E
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):355-8. PubMed ID: 17438479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B; Lapuebla C; Vidal-Tegedor B
    Int J Infect Dis; 2005 Jul; 9(4):195-200. PubMed ID: 15964537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy, virological response, and time to resistance in the Dakar cohort.
    Tournoud M; Etard JF; Ecochard R; DeGruttola V
    Stat Med; 2010 Jan; 29(1):14-32. PubMed ID: 19941299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of adding etravirine on complexity index and patients' perceived complexity.
    Calvo-Cidoncha E; González-Bueno J; Almeida-González CV; Morillo-Verdugo R
    J Clin Pharm Ther; 2014 Apr; 39(2):154-7. PubMed ID: 24372048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term adherence to HAART in Senegal].
    Bastard M; Fall MB;
    Bull Soc Pathol Exot; 2014 Oct; 107(4):241-3. PubMed ID: 24615434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.